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Comparison of Results for Morphine Urinalyses by Radioimmunoassay and Thin-Layer Chromatography in a Narcotic Clinic Setting
Robert J. Kokoski and Mlshrllal Jam Radioimmunoassay (RIA) and thin-layer chromatography (TIC) were compared for morphine detection in an actual narcotic clinic setting. A choice of unnes from all those screened by TLC allowed a critical comparison as to actual use or non-use of narcotic drugs, rather than a sampling at random in whlch the question of possible false positives or negatives cannot be conclusively answered. Although RIA is more sensitive than TIC, its advantage is apparent only in those cases where urine specimens are difficult to obtain frequently regularly or where the use of morphine is suspected by the positive identification of quinine in urine that was morphine-negative by TIC. In a selected group of negative and positive specimens chosen without conscious bias, the two methods gave consistently similar results, indicating that the modified TIC method provided few or no false positives or negatives if the negatives were from those cases that were not positive anytime up to 3-4 days before urine collection. We conclude that AlA can be of these methods and found that, because of its greater sensitivity, radioimmunoassay detects more morphine-positive urines than do the widely used thin-layer chromatographic procedures.
In the present study we compare morphine detection by radioimmunoassay (RIA) and by thin-layer chromatography (TLC) in a clinical setting. Possible interference by oral naloxone administration was also investigated. The study was done by superimposing RIA on selected urine specimens obtained from a clinic population that had initially been screened by TLC.
Materials and Methods
Materials:
All chemicals used were of reagent grade. Test kits for RIA ("ABUSCREEN 3H") were obtained fist clinic program. Frequency of urine collection varied from daily to once a week, depending on the results of previous urinalyses; i.e., patients whose specimens gave negative results were able to earn "days off" from an initial routine of daily testing. All urines were analyzed by the TLC procedure described below, which is routinely used for screening all specimens obtained from the program. Thin-layer chromatography: To 10 ml of urine, 1 ml of hydrochloric acid(12mol/liter) was added and the mixture autoclavedat 120 #{176}C for15 mm. The hydrolyzed urine was cooled,made alkaline with 1.5ml of ammonium hydroxide (15mol/liter) and extracted by shaking with 40 ml of chloroform-isopropanol (9:1by vol). The extractwas acidified with a few drops of HC1 in methanol (1 mi/dI)and evapo- analyzedby TLC, selected samples were tested by RIA by the "Abuscreen" procedure (Roche), using the suggested 60 ng/ml cutoff concentration for a positive determination. Based on the results of TLC, the criteria used for the selection of urines for RIA were as follows:
#{149} Negative urines on any Thursday or Monday for patients who had a morphine-positive on any day up through the previous three or four days, respectively.
#{149} Morphine-positive urines in this group. 
Results and DIscussion
The results obtained were classified into the following groups: Table 1 .
Naloxone patients: Some patients in the treatment program were on a contingency naloxone study, i.e., upon showing morphine-positive urines by TLC, naloxone was administered in single, daily oral doses starting at 500 mg and increasing to 2000 mg. On testing urines from these patients by TLC and RIA, we found that 10 of 13 such samples from patients receiving naloxone 24 h before urine collection were negative for morphine both by RIA and TLC.
This suggests that the three urines found to be positive by RIA may be explained by previous narcotic use rather than by crossreactivity of naloxone or its metabolites.
Mule et
al. (3) showed that naloxone at a concentration of 290 ig/ ml was equivalentto 1 ig of morphine per milliliter in its reactivity with RIA. It is very unlikely that 24 h afteradministration, sufficient naloxone would be present in the urine to cross-react and indicatemorphine-positivity by RIA. We findthataftera single 2000-mg oraldose ofnaloxone isadministered(withno otherdrugsbeing taken) urine collected at 2, 5, and 12 h will be morphine-positive by RIA, but at 25.5 h after naloxone administration, it will be morphine-negative (<60-ng) ( 
